Marksans Pharma Ltd.

BSE: 524404 | NSE: MARKSANS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE750C01026 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Marksans Pharm Marksans Pharma Ltd. | BSE 180.35 0.60 (0.33%) | NSE 180.29 0.76 (0.42%) | Trade | Add

BSE Live

Dec 31, 16:01

180.35 0.60 (0.33%)

Volume

AVERAGE VOLUME

5-Day

31,694

10-Day

31,229

30-Day

41,684

38,788

Prev. Close

179.75
Open Price

179.80

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Dec 31, 15:57

180.29 0.76 (0.42%)

Volume

AVERAGE VOLUME

5-Day

486,112

10-Day

504,450

30-Day

673,687

343,760

Prev. Close

179.53
Open Price

180.00

Bid Price (Qty.)
180.29 (10)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Balance Sheet of Marksans Pharma (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	45.32	45.32	45.32	40.93	40.93
Total Share Capital	45.32	45.32	45.32	40.93	40.93
Reserves and Surplus	2,421.60	2,019.74	1,699.85	1,161.34	845.56
Total Reserves and Surplus	2,421.60	2,019.74	1,699.85	1,161.34	845.56
Total Shareholders Funds	2,466.91	2,065.05	1,745.16	1,202.27	886.49
Minority Interest	22.47	20.85	19.91	20.70	18.86
NON-CURRENT LIABILITIES
Long Term Borrowings	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liabilities [Net]	3.66	10.62	15.39	17.62	8.06
Other Long Term Liabilities	269.25	190.02	65.69	41.43	14.33
Long Term Provisions	0.00	4.56	3.25	1.86	2.11
Total Non-Current Liabilities	272.91	205.20	84.33	60.91	24.50
CURRENT LIABILITIES
Short Term Borrowings	23.09	29.09	41.59	41.29	18.74
Trade Payables	305.70	268.28	230.60	200.08	168.66
Other Current Liabilities	148.56	90.53	67.48	114.12	109.14
Short Term Provisions	0.00	1.96	1.33	0.72	1.85
Total Current Liabilities	477.34	389.85	340.99	356.22	298.40
Total Capital And Liabilities	3,239.63	2,680.95	2,190.39	1,640.10	1,228.25
ASSETS
NON-CURRENT ASSETS
Tangible Assets	886.41	675.71	379.64	341.59	248.42
Intangible Assets	54.62	60.73	68.17	56.69	60.94
Capital Work-In-Progress	9.00	5.38	7.25	0.70	5.60
Fixed Assets	968.14	745.85	457.69	400.86	321.04
Non-Current Investments	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets [Net]	0.00	0.00	0.00	3.86	0.80
Long Term Loans And Advances	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	26.44	33.11	18.91	4.16	4.16
Total Non-Current Assets	1,035.51	818.46	515.09	438.90	326.00
CURRENT ASSETS
Current Investments	0.74	26.99	0.54	0.44	0.00
Inventories	845.52	617.94	484.74	424.44	404.32
Trade Receivables	540.04	453.18	416.85	394.78	271.38
Cash And Cash Equivalents	704.21	673.58	714.96	349.27	212.29
Short Term Loans And Advances	0.00	0.00	0.00	0.00	0.00
OtherCurrentAssets	113.61	90.80	58.21	32.28	14.26
Total Current Assets	2,204.12	1,862.49	1,675.30	1,201.20	902.25
Total Assets	3,239.63	2,680.95	2,190.39	1,640.10	1,228.25
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	34.15	45.87	9.31	17.02	19.78
BONUS DETAILS
Bonus Equity Share Capital	0.00	0.00	0.00	0.00	0.00
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.00	0.00	0.00	0.00	0.00
Non-Current Investments Unquoted Book Value	0.00	0.00	0.00	0.00	0.00
CURRENT INVESTMENTS
Current Investments Quoted Market Value	0.00	0.00	0.00	0.00	0.00
Current Investments Unquoted Book Value	0.74	26.99	0.00	0.00	0.00